bay-k-8644 has been researched along with endothelin-1 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpech, N; Potreau, D; Soustre, H | 1 |
| Kawasaki, H | 1 |
| Diéguez, G; Fernández, N; García, AG; García, JL; López, MG | 1 |
| Held, B; Pearson, HA; Pocock, JM | 1 |
| Hadziselimovic, R; Hukovic, N | 1 |
| Andric, SA; Koshimizu, T; Stojilkovic, SS; Tomić, M; Yuan, D; Zivadinovic, D | 1 |
| Carvalho, MH; David, FL; Fortes, ZB; Montezano, AC; Nigro, D; Rebouças, NA; Tostes, RC | 1 |
| Chang, TH; Wang, HL; Zhang, XH | 1 |
| Hattori, T; Wang, PL | 1 |
| Kim, SC; Lee, MY; Lee, SY; Myung, SC; Park, SH; Yum, SH | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T; Ozawa, Y | 1 |
| De Mey, JG; Hilgers, RH | 1 |
12 other study(ies) available for bay-k-8644 and endothelin-1
| Article | Year |
|---|---|
Endothelin-1 inhibits L-type Ca2+ current enhanced by isoprenaline in rat atrial myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Colforsin; Cyclic AMP; Endothelin-1; Heart Atria; Isoproterenol; Myocardium; Patch-Clamp Techniques; Protein Kinase Inhibitors; Rats | 1997 |
[Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Nifedipine; Norepinephrine; Phorbol 12,13-Dibutyrate; Potassium; Protein Kinase C; Rats; Rats, Wistar; Serotonin; Staurosporine; Streptozocin; Vasoconstriction; Vasoconstrictor Agents | 1997 |
PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Agonists; Coronary Circulation; Dihydropyridines; Endothelin-1; Female; Goats; Heart; Heart Rate; Infusions, Intravenous; Shock, Cardiogenic; Thiazoles; Ventricular Function, Left | 1998 |
Endothelin-1 inhibits voltage-sensitive Ca2+ channels in cultured rat cerebellar granule neurones via the ET-A receptor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Cerebellum; Dose-Response Relationship, Drug; Endothelin-1; Male; Nerve Tissue Proteins; Neurons; Oligopeptides; Patch-Clamp Techniques; Peptides, Cyclic; Potassium; Potassium Chloride; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Cholinergic; Receptors, Endothelin; Second Messenger Systems; Viper Venoms | 1998 |
Endothelin 1 action on isolated rat stomach and the role of calcium ions in ET 1 induced depolarization of smooth muscle cells BC3H1.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic Antagonists; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cell Line; Cholinergic Antagonists; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Membrane Potentials; Mice; Muscle Contraction; Muscle, Smooth; Nitrendipine; omega-Conotoxin GVIA; Peptides; Serotonin Antagonists; Stomach; Thapsigargin | 1998 |
Characterization of a plasma membrane calcium oscillator in rat pituitary somatotrophs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Cell Membrane; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide-Gated Cation Channels; Endothelin-1; Female; Gonadotropin-Releasing Hormone; Ion Channels; Ionomycin; Kinetics; Nifedipine; Pituitary Gland, Anterior; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thyrotropin-Releasing Hormone | 1999 |
Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Caffeine; Calcium; Calcium Channel Agonists; Desoxycorticosterone; Endothelin-1; Female; Hypertension; Male; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sex Characteristics; Vasoconstriction | 2002 |
Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Angiotensin II; Animals; Antihypertensive Agents; Benzylisoquinolines; Endothelin-1; Guinea Pigs; Hypertension, Pulmonary; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Pulmonary Artery; Rats; Rats, Sprague-Dawley; SRS-A | 2002 |
Calcium antagonists cause dry mouth by inhibiting resting saliva secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenocarcinoma; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Cell Line, Tumor; Depression, Chemical; Endothelin-1; Humans; Imidazoles; Isoenzymes; Microscopy, Fluorescence; Muscarinic Agonists; Norepinephrine; Phospholipase C beta; Saliva; Submandibular Gland Neoplasms; Type C Phospholipases; Vasoconstrictor Agents; Xerostomia | 2007 |
Contractile changes of the clitoral cavernous smooth muscle in female rabbits with experimentally induced overactive bladder.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenergic alpha-Agonists; Amides; Animals; Antihypertensive Agents; Calcium Channel Agonists; Clitoris; Dose-Response Relationship, Drug; Endothelin-1; Female; Isometric Contraction; Models, Animal; Muscle Relaxants, Central; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Oligopeptides; Peptides, Cyclic; Phenylephrine; Piperidines; Potassium; Pyridines; Rabbits; Urinary Bladder, Overactive; Vasodilator Agents | 2008 |
Effect of long-term streptozotocin-induced diabetes on coronary vasoconstriction in isolated perfused rat heart.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Calcium Channel Agonists; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin-1; In Vitro Techniques; Male; Perfusion; Potassium; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bosentan; Calcium Channel Agonists; Dose-Response Relationship, Drug; Electric Stimulation; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Gap Junctions; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Mesenteric Arteries; Muscle, Smooth, Vascular; Myography; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Paracrine Communication; Phenylephrine; Rats; Rats, Inbred WKY; Receptors, Endothelin; Sulfonamides; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents | 2009 |